Role of hypoxia-inducible factor-α in hepatitis-B-virus X protein-mediated MDR1 activation

Biochemical and Biophysical Research Communications

Volumn 357, Issue 2, 2007, Pages 567-573

  Han, Hyo Kyung ^a   Han, Chang Yeob ^a   Cheon, Eun Pa ^a   Lee, Jaewon ^b   Kang, Keon Wook ^a  

^a Chosun University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Chemoresistance; HBx; HIF 1 ; MDR1

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN 1; SMALL INTERFERING RNA; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL LEVEL; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE ACTIVITY; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HEPATOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; TRANSCRIPTION INITIATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; P-GLYCOPROTEIN; RATS; RECOMBINANT PROTEINS; RHODAMINE 123; VERAPAMIL; VIRAL REGULATORY PROTEINS;

HEPATITIS B VIRUS;

EID: 34247160536     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.012     Document Type: Article

References (28)

1. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. 2 (2002) 48-58
2. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J., Juijn J.A., Baas F., and Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57 (1997) 3537-3547
3. Mistry P., Stewart A.J., Dangerfield W., Okiji S., Liddle C., Bootle D., Plumb J.A., Templeton D., and Charlton P. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res. 61 (2001) 749-758
4. Zhang X., Zhang H., and Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J. Lab. Clin. Med. 147 (2006) 58-66
5. Kim C.M., Koike K., Saito I., Miyamura T., and Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 (1991) 317-320
6. Gottlob K., Fulco M., Levrero M., and Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J. Biol. Chem. 273 (1998) 33347-33353
7. Koike K., Moriya K., Yotsuyanagi H., Iino S., and Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Invest. 94 (1994) 44-49
8. Huang C.C., Wu M.C., Xu G.W., Li D.Z., Cheng H., Tu Z.X., Jiang H.Q., and Gu J.R. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J. Natl. Cancer Inst. 84 (1992) 262-264
9. Sukhai M., and Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J. Pharm. Pharmacol. Sci. 3 (2000) 268-280
10. Doong S.L., Lin M.H., Tsai M.M., Li T.R., Chuang S.E., and Cheng A.L. Transactivation of the human MDR1 gene by hepatitis B virus X gene product. J. Hepatol. 29 (1998) 872-878
11. Schreiber E., Harshman K., Kemler I., Malipiero U., Schaffner W., and Fontana A. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nuc. Acid Res. 18 (1990) 5495-5503
12. Moon E.J., Jeong C.H., Jeong J.W., Kim K.R., Yu D.Y., Murakami S., Kim C.W., and Kim K.W. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J. 18 (2004) 382-384
13. Doppenschmitt S., Spahn-Langguth H., Regardh C.G., and Langguth P. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein. J. Pharm. Sci. 88 (1999) 1067-1072
14. Yamada T., Takaoka A.S., Naishiro Y., Hayashi R., Maruyama K., Maesawa C., Ochiai A., and Hirohashi S. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res. 60 (2000) 4761-4766
15. Geick A., Eichelbaum M., and Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276 (2001) 14581-14587
16. Kullak-Ublick G.A., and Becker M.B. Regulation of drug and bile salt transporters in liver and intestine. Drug Metab. Rev. 35 (2003) 305-317
17. Chin K.V., Ueda K., Pastan I., and Gottesman M.M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255 (1992) 459-462
18. Ohga T., Uchiumi T., Makino Y., Koike K., Wada M., Kuwano M., and Kohno K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273 (1998) 5997-6000
19. Combates N.J., Rzepka R.W., Chen Y.N., and Cohen D. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J. Biol. Chem. 269 (1994) 29715-29719
20. Fujita T., Ito K., Izumi H., Kimura M., Sano M., Nakagomi H., Maeno K., Hama Y., Shingu K., Tsuchiya S., Kohno K., and Fujimori M. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Clin. Cancer Res. 11 (2005) 8837-8844
21. Chen G.K., Sale S., Tan T., Ermoian R.P., and Sikic B.I. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Mol. Pharmacol. 65 (2004) 906-916
22. Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., and Colgan S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62 (2002) 3387-3394
23. Comerford K.M., Cummins E.P., and Taylor C.T. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia. Cancer Res. 64 (2004) 9057-9061
24. Zhu H., Chen X.P., Luo S.F., Guan J., Zhang W.G., and Zhang B.X. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J. Exp. Clin. Cancer Res. 24 (2005) 565-574
25. Bonin S., Pascolo L., Croce L.S., Stanta G., and Tiribelli C. Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases. Mol. Med. 8 (2002) 318-325
26. Semenza G.L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35 (2000) 71-103
27. Semenza G.L., Agani F., Iyer N., Kotch L., Laughner E., Leung S., and Yu A. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann. N. Y. Acad. Sci. 874 (1999) 262-268
28. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004) 1-12